In today's interconnected world, we are currently faced with many global challenges and opportunities surrounding infectious diseases. At Alveo, we're tackling these head-on by creating technology platforms that provide rapid, reliable, and economical cloud-based diagnostics for use by everyone, anytime, everywhere.
Location: United States, California, San Francisco
Employees: 51-200
Total raised: $38M
Founded date: 2014
Investors 5
| Date | Name | Website |
| - | Black Diam... | bdventures... |
| 07.06.2021 | 3E Biovent... | 3ebiovc.co... |
| - | Civilizati... | civilizati... |
| 17.07.2025 | Supply Cha... | supplychan... |
| - | Celesta Ca... | celesta.vc |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 04.01.2018 | Series A | $38M | - |
Mentions in press and media 7
| Date | Title | Description |
| 25.08.2026 | Can smarter surveillance help poultry farms catch bird flu earlier? | Rapid on-farm pathogen testing firm Alveo Technologies has teamed up with wildfowl surveillance specialist AgriNerds to create an early warning system for avian flu it claims could dramatically improve poultry farmers’ ability to detect and... |
| 18.02.2025 | California’s H5N1 Emergency Declaration Highlights Need for an Urgent National Response to Avian Flu | Shaun Holt, CEO of Alveo Technologies The H5N1 virus is spreading so rapidly among cattle in California that Gavin Newsom declared a state of emergency. Sick cattle not only produce less milk, but their milk is also infected with the virus,... |
| 26.10.2023 | The Week in AgriFoodTech: URB-E pivots to last-mile delivery, GoodBytz bags $12m, a new fund for regen ag | This week, URB-E, a company best known for developing e-scooters, took a sharp left turn with both its business and its brand. And while funding rounds are low and slow of late, they nonetheless trickle in despite the tough economic times. ... |
| 10.07.2020 | Bob Goeltz bolts Unity Biotechnology to become CFO at Arcus Biosciences; John Johnson tapped for his latest CEO gig | Bob Goeltz → A press release earlier in the week noted that Bob Goeltz left his CFO post at Unity Biotechnology “to pursue a new opportunity.” We now know what that opportunity is, joining Terry Rosen’s crew at Arcus Bio... |
| 30.04.2020 | Alveo partners with Johnson & Johnson to develop in-home COVID-19 testing | Johnson & Johnson will help support Alveo through its clinical trials and FDA approvals [Editor's note: Future of Behavioral and Mental Health with BetterHelp, Headspace, Ginger.io, Providence Hospitals, UnitedHealthcare Optum, Khosla V... |
| 08.01.2018 | Alveo Closes $38M in Series A Financing | Alveo Technologies, Inc., a San Francisco, CA-based maker of affordable and accessible infectious disease diagnostic devices, closed a $38m Series A financing. The round was led by Maxim Merchant Capital, a division of Maxim Group LLC, and ... |
| 04.01.2018 | Alveo Closes $38 Million in Series A Financing to Create Accessible Diagnostics Devices | A recent article on Alveo Technologies $38M Series A – Read the full article |